Cancer Therapeutic Drugs Market Size, Share, Opportunities, And Trends By Indication (Skin Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, and Others), By Product Type (Revlimid, Avastin, Herceptin, Rituxan, and Others), And By Geography - Forecasts From 2025 to 2030

Cancer Therapeutic Drugs Market Size:

The Cancer Therapeutic Drugs Market is expected to grow from US$238.353 billion in 2025 to US$361.007 billion in 2030, at a CAGR of 8.66%.

Cancer Therapeutic Drugs Market Trends:

The cancer therapeutic drugs market is expected to grow at a fast pace during the forecast period due to the growing incidence of cancers worldwide. Geographically, North America is expected to hold the highest market share owing to the highest health spending of the United States among all the developed regions, in addition to having a high cancer prevalence in the country. The growing adoption of unhealthy living conditions is further driving the market growth during the forecast period.

Furthermore, growing cancer drug spending is driving the growth of the global cancer therapeutics market during the forecast period. The growing number of clinical trials has improved the chances of new innovations for targeted cancer treatment, driving market growth during the forecast period and beyond. Growing health awareness among people worldwide will lead to early diagnosis, further leading to the treatment of cancer, when detected at an early stage, thus, propelling the market growth in the forecast period.

Cancer Therapeutic Drugs Market Growth Drivers:

• Rising cancer incidences worldwide
• Growing cancer drug spending
• Increasing health awareness among people worldwide

Cancer Therapeutic Drugs Market Restraints:

• The high cost of cancer treatment

Cancer Therapeutic Drugs Market Industry Updates:

• On 17th June 2019, Pfizer announced that it has entered into a definitive merger agreement under which it will acquire Array Pharma.
• On 31st August 2018, Servier Pharmaceuticals announced that it has completed the acquisition of Shire’s oncology business.

Major industry players profiled as part of the report are Pfizer Inc., Celgene Corporation, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation, Janssen Global Services, LLC, Eli Lilly and Company, Merck & Co., Inc., and Astellas Pharma Inc.

Cancer Therapeutic Drugs Market Scope:

Report Metric	Details
Cancer Therapeutic Drugs Market Size in 2025	US$238.353 billion
Cancer Therapeutic Drugs Market Size in 2030	US$361.007 billion
Growth Rate	CAGR of 8.66%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Indication Product Type Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Cancer Therapeutic Drugs Market	Pfizer Inc. Celgene Corporation F. Hoffmann-La Roche Ltd Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation
Customization Scope	Free report customization with purchase

 

The cancer therapeutic drugs market is analyzed into the following segments:

By Indication
Skin Cancer
Lung Cancer
Breast Cancer
Prostate Cancer
Others

By Product Type
Revlimid
Avastin
Herceptin
Rituxan
Others

By Geography

North America
USA
Canada
Mexico

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others

---

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Overview and Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Prevalence
4.5.1. By age group
4.5.2. By region
4.6. Product Pipeline
4.7. Innovations
5. CANCER THERAPEUTIC DRUGS MARKET BY INDICATION
5.1. Skin Cancer
5.2. Lung Cancer
5.3. Breast Cancer
5.4. Prostate Cancer
5.5. Others
6. CANCER THERAPEUTIC DRUGS MARKET BY PRODUCT TYPE
6.1. Revlimid
6.2. Avastin
6.3. Herceptin
6.4. Rituxan
6.5. Others
7. CANCER THERAPEUTIC DRUGS MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Pfizer Inc.
9.2. Celgene Corporation
9.3. F. Hoffmann-La Roche Ltd
9.4. Bristol-Myers Squibb Company
9.5. Novartis Pharmaceuticals Corporation
9.6. Janssen Global Services, LLC
9.7. Eli Lilly and Company
9.8. Merck & Co., Inc.
9.9. Astellas Pharma Inc.
LIST OF FIGURES
LIST OF TABLES

Pfizer Inc.
Celgene Corporation
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Novartis Pharmaceuticals Corporation
Janssen Global Services, LLC
Eli Lilly and Company
Merck & Co., Inc.
Astellas Pharma Inc.